Oramed Pharmaceuticals (ORMP) Non Operating Investment Income (2011 - 2014)

Oramed Pharmaceuticals (ORMP) has 3 years of Non Operating Investment Income data on file, last reported at $160000.0 in Q3 2014.

• Quarterly Non Operating Investment Income rose 200.52% year-over-year to $160000.0 in Q3 2014, while the trailing twelve-month figure through Aug 2014 was $168391.0 (up 287.1% YoY) and the FY2014 annual result came in at $80000.0, up 188.89% from the prior year.
• Non Operating Investment Income grew to $160000.0 in Q3 2014, from -$36000.0 in the prior quarter.
• In the past five years, Non Operating Investment Income ranged from a high of $1.0 million in Q2 2011 to a low of -$159178.0 in Q3 2013.
• A 3-year average of $138924.4 and a median of $22214.0 in 2013 frame the typical range for Non Operating Investment Income.
• The widest YoY moves for Non Operating Investment Income: up 200.52% in 2014, down 294.69% in 2014.
• Tracing ORMP's Non Operating Investment Income over 3 years: stood at $1.0 million in 2011, then sank by 98.21% to $18454.0 in 2013, then surged by 767.02% to $160000.0 in 2014.
• The last three Non Operating Investment Income figures came in at $160000.0 (Q3 2014), -$36000.0 (Q2 2014), and $25937.0 (Q1 2014), per Business Quant data.